Laevolac Syrup 180 ml 66.7 gr / 100 ml

WARNINGS
The abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In the most severe cases the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in the case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause addiction (and, therefore, possible need to gradually increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). As the active ingredient of Laevolac is a non-absorbable sugar, at the recommended doses it is not contraindicated in diabetic patients. However, due to the presence of other sugars such as lactose, galactose and tagatose, in case of prolonged treatment, for such patients it is advisable to consult a doctor. Keep out of reach of children. Precautions for use In children under 12 years the medicine can 'be used only after consulting your doctor. The treatment of chronic or recurrent constipation always requires the intervention of the doctor for the diagnosis, the prescription of drugs and the surveillance during the course of therapy. Consult your doctor when the need for the laxative derives from a sudden change in previous bowel habits (frequency and characteristics of bowel movements) that has lasted for more than two weeks or when the use of the laxative fails to produce effects. It is also advisable that elderly people or those in poor health conditions consult their doctor before using the medicine.
PHARMACOTHERAPEUTIC CATEGORY
Laxatives
STORAGE
No special storage precautions.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the excipients. Laxatives are contraindicated in subjects with acute abdominal pain or of unknown origin, nausea or vomiting, intestinal obstruction or stricture, rectal bleeding of unknown origin, severe dehydration. Contraindicated in subjects with galactosemia. Generally contraindicated during pregnancy and lactation.
NAME
LAEVOLAC
EXCIPIENTS
Syrup: sorbic acid (E 200) g 0.08, purified water qs 100 ml. Sachets: lemon flavor 0.05 g.
SIDE EFFECTS
Occasionally: isolated cramping pains or abdominal colic, more frequent in cases of severe constipation. Occasionally: flatulence. These symptoms are generally mild and disappear spontaneously after the first days of treatment. Only in case of diarrhea it is advisable to suspend the therapy. In exceptional cases, after long treatment, the possibility of a loss of electrolytes may occur.
PREGNANCY AND BREASTFEEDING
There are no adequate and well-controlled studies on the use of the drug in pregnancy or breastfeeding. Therefore, the medicine should be used only in case of need, under the direct control of the doctor, after evaluating the expected benefit to the mother in relation to the possible risk to the fetus or infant.
INDICATIONS
Adults: short-term treatment of occasional constipation. Children and infants: short-term treatment of occasional constipation.
INTERACTIONS
Laxatives can reduce the time spent in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Avoid ingesting laxatives and other drugs at the same time: after taking a medicine, leave an interval of at least 2 hours before taking the laxative. Laevolac can lead to increased toxicity of digitalis due to potassium depletion. Furthermore, a synergistic effect with neomycin is possible. Broad spectrum antibacterial agents, administered orally at the same time as lactulose, can reduce its degradation by limiting the possibility of acidification of the intestinal contents and, consequently, the therapeutic efficacy.
DOSAGE
The correct dose is the minimum sufficient to produce easy evacuation of soft stools. It is advisable to initially use the minimum doses provided. When necessary, the dose can then be increased, but never exceed the maximum indicated. Take preferably in the evening. Adults: syrup, initial dose, maintenance dose. Mild constipation 1 tablespoon / day 2 coffee spoons / day; severe constipation 1-2 tablespoons / day 2-3 coffee spoons / day; stubborn constipation 2-3 tablespoons / day 2-4 coffee spoons / day. Sachets: 1-2 sachets / day. Children, syrup: initial dose maintenance dose 1-6 years 1-2 teaspoons / day 1 teaspoon / day 6-14 years 1 tablespoon / day 2 teaspoons / day. Sachets 1 / 2-1 sachet / day. Infants: initial dose maintenance dose. Syrup 1 teaspoon / day 1 teaspoon / day 1 tablespoon = 15 ml = 10 g of lactulose 1 teaspoon = 5 ml = 3.3 g of lactulose. Laxatives should be used as infrequently as possible and for no more than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case.
ACTIVE PRINCIPLES
Lactulose